Advaxis
Clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases. Learn more
Launch date
Employees
Market cap
AUD1.3m
Enterprise valuation
AUD7m (Public information from Sep 2024)
Share price
$0.10105 ADXS
Princeton New Jersey (HQ)
Authorizing premium user...